已收盘 09-20 16:00:00 美东时间
-0.042
-7.32%
Quoin Pharmaceuticals (NASDAQ:QNRX) has announced that its CEO, Michael Myers, and COO, Denise Carter, have recently made significant purchases of the Co.’s ADSs, signaling their confidence in the com...
09-09 21:08
Quoin Pharmaceuticals (NASDAQ:QNRX) reported its Q4 earnings results on Wednesd...
03-14 04:15
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
03-13 18:15
© Reuters. 美国股市收低;截至收盘道琼斯工业平均指数下跌1.04% 纽约收盘时,道琼斯工业平均指数下跌1.04%,而标准普尔500指数跌幅为1....
03-06 05:30
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 350 points on Tuesday. The Dow traded down 0.91% to 38,633.24 while the NASDAQ fell 1.85% to 15,906.92. The S&P 500 also fell, dropping, 1.05% to 5,076.98.
03-06 03:11
Quoin Pharmaceuticals shares are trading lower by 46.9% Tuesday morning. The company announced the pricing of a $6.5 million public offering.
03-05 23:38
Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a specialty pharmaceutical company focused on rare and orphan diseases, today announced the pricing of its "reasonable best efforts" public offering of
03-05 21:02
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.2% on Monday. The Dow traded down 0.25% to 38,988.86 while the NASDAQ fell 0.18% to 16,245.30. The S&P 500 also fell, dropping, 0.06% to 5,134.05.
03-05 01:05
Quoin announced clearance from the U.S. Food and Drug Administration (FDA) to recruit teen subjects aged 14 years and older into its two ongoing clinical trials for QRX003, which is being developed as a potential treatment for Netherton Syndrome.
03-04 23:19
U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, the Dow traded down 0.34% to 38,951.34 while the NASDAQ fell 0.13% to 16,253.77. The S&P 500 also fell, dropping, 0.12% to 5,131.69.
03-04 22:44